Seattle, February 6, 2015–PATH has named Kathy Cahill as its vice president for International Development, effective March 2, 2015. Cahill will be based in PATH’s Seattle headquarters.
As vice president for PATH’s International Development division, Cahill will direct strategy development and implementation across the organization’s international presence in Asia, Africa, Eastern Europe, and Latin America. She also will serve as a member of PATH’s executive leadership team.
“I am pleased to announce that Kathy will be leading a critical area of our work–PATH’s international presence, which spans over 70 countries,” commented Steve Davis, president and CEO at PATH. “Her lifelong passion and commitment to global health positions her to effectively advance PATH’s innovative approach to international health and work alongside countries to address their greatest health needs.”
Cahill’s career in public health includes experience across sectors, from government to the private sector to nonprofits. Cahill has more than 20 yearsÂ experience in public health with a background in leadership of programs for sexually transmitted infections, childhood immunization, HIV, noncommunicable diseases, and maternal and child health. Most recently, she served as interim vice president for Public Health Impact at PATH, a position now held by Dr. David Fleming.
“I look forward to guiding PATH’s International Development division by partnering with countries and communities in the many low-resource settings where PATH works,” said Cahill. “PATH’s legacy of innovative, country-led approaches to tackling health challenges endures, and, in this role, I will focus and foster our efforts toward achieving meaningful impact.”
Passionate and proven leader
Previously, Cahill was deputy director of Integrated Health Solutions for Global Health at the Bill & Melinda Gates Foundation, where she led development of the foundation’s strategy for tobacco control, was program officer for health systems, and deputy director for Integrated Delivery Services.
Prior to that, Cahill worked at the US Centers for Disease Control and Prevention as director for Policy, Planning, and Evaluation and was responsible for agency annual budget strategy and policy development. Her previous role at the agency was division director for Immunization Service Delivery, with responsibilities that included implementation of a White House initiative on increasing childhood immunization rates in the United States. She led many new agency wide initiatives at the CDC including CDC’s first bioterrorism grant program to 50 states.
Cahill is senior partner and founder of AHISMA Group, a global health company focused on health systems strengthening, policy development, program assessment, and monitoring and evaluation of infectious and noncommunicable disease programs in low-resource settings.
Cahill holds a Master of Public Health degree from the University of North Carolina at Chapel Hill and a Bachelor of Arts degree from Central Washington University.
PATH is the leader in global health innovation. An international nonprofit organization, PATH saves lives and improves health, especially among women and children. Accelerating innovation across five platforms–vaccines, drugs, diagnostics, devices, and system and service innovations–PATH harnesses its entrepreneurial insight, scientific and public health expertise, and passion for health equity. By mobilizing partners around the world, PATH takes innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. With these key partners, PATH delivers measurable results that disrupt the cycle of poor health. Learn more at www.path.org.